Stifel Financial
APLT

Stifel Financial’s Applied Therapeutics APLT Stock Holding History

Stifel Financial’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-132,596
Closed -$2.75M – 3328
2021
Q2 		$2.75M Hold
132,596
– – ﹤0.01% 1392
2021
Q1 		$2.49M Hold
132,596
– – ﹤0.01% 1379
2020
Q4 		$2.92M Hold
132,596
– – 0.01% 1153
2020
Q3 		$2.75M Buy
+132,596
New +$3.45M 0.01% 1059

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Stifel Financial's APLT Position: Q3 2021 in Review

Stifel Financial sold out of Applied Therapeutics (APLT) in Q3 2021, closing a stake of 132,596 shares — an estimated $2.75M sold.

Stifel Financial first reported a position in APLT in Q3 2020 and held it in 4 quarters. The position peaked at $2.92M in Q4 2020. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2021.

  • Stifel Financial reported no remaining Applied Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Stifel Financial sold 132,596 Applied Therapeutics shares in Q3 2021, an estimated $2.75M.
  • Stifel Financial first reported a position in Applied Therapeutics in Q3 2020 and held it in 4 quarters.
  • Stifel Financial's Applied Therapeutics position peaked at $2.92M in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2021.

Based on Stifel Financial's 13F filing for Q3 2021, filed 15 Nov 2021.